The weekly litigation news digest is live. Subscribe now

IP Verse

Heterodimers Of Glutamic Acid - EP3699162

The patent EP3699162 was granted to Molecular Insight Pharmaceuticals on Jun 29, 2022. The application was filed on Nov 7, 2007 under application number EP19214298A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3699162

MOLECULAR INSIGHT PHARMACEUTICALS
Application Number
EP19214298A
Filing Date
Nov 7, 2007
Status
Granted And Under Opposition
May 27, 2022
Publication Date
Jun 29, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TELIX INNOVATIONSJan 10, 2023DE CLERCQ & PARTNERSADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004002478
DESCRIPTIONUS2004054190
DESCRIPTIONWO0222627
DESCRIPTIONWO03060523
OPPOSITIONUS2004054190

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents